.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Managing Neuromyelitis Optica Spectrum Disorders (NMOSD)

Recommendations for identifying neuromyelitis optica spectrum disorders in the community and using immunosuppressive therapy to help prevent acute attacks.

EP. 1: Raising Awareness About NMOSD

September 21st 2021

Mayo Clinic’s Brian G. Weinshenker, MD, compares multiple sclerosis with neuromyelitis optica spectrum disorders (NMOSD) and explains why community neurologists need to receive more education on NMOSD risk factors and symptoms.

EP. 2: Receiving a Diagnosis of NMOSD

September 21st 2021

Doug and Kim, patients with neuromyelitis optica spectrum disorders, describe the types of symptoms that prompted each of them to seek an evaluation by a neurologist for an eventual diagnosis of a neuromyelitis optica spectrum disorder.

EP. 3: The Guthy-Jackson Charitable Foundation for NMOSD

September 28th 2021

Jacinta M. Behne, MA, describes how the Guthy-Jackson Charitable Foundation supports patients with neuromyelitis optica spectrum disorders.

EP. 4: Identifying and Managing NMOSD

September 28th 2021

Types of testing that can help neurologists distinguish between acute attacks of neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis, as well as therapies that can be used to help manage patients with NMOSD.

EP. 5: NMOSD Acute Attack Prevention

October 5th 2021

An overview of newer preventive therapies approved for acute attacks of neuromyelitis optica spectrum disorders, and variables that impact treatment selection.

EP. 6: Treating NMOSD During COVID-19

October 5th 2021

What to know about treating patients with neuromyelitis optica spectrum disorders throughout the COVID-19 pandemic.

EP. 7: Navigating NMOSD Infusion-Based Treatment

October 12th 2021

Kim, a patient with neuromyelitis optica, describes what it has been like receiving rituximab infusions as preventive therapy, and shares advice for others who are about to embark on a similar treatment journey.

EP. 8: Treating NMOSD: What to Expect

October 12th 2021

Neuromyelitis optica patient Doug highlights the types of treatments he has received since his diagnosis and provides suggestions to patients on navigating therapy, especially during the COVID-19 pandemic.

EP. 9: NMOSD Research Programs

October 19th 2021

Jacinta M. Behne, MA, of the Guthy-Jackson Charitable Foundation, reacts to the types of research programs the organization has been involved in, regarding better treatments for patients with neuromyelitis optica spectrum disorders.

EP. 10: Support For Patients With NMOSD

October 19th 2021

Patients with neuromyelitis optica spectrum disorders highlight the types of resources and support that have helped them manage their neurological condition.